Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Ranibizumab plus Laser for BRVO
NCT02527733Phase 4Unknown
- Sponsor
- Fukushima Medical University
- Start
- Jun 2015
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in branch retinal vein occlusion (BRVO), sponsored by Fukushima Medical University. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT02527733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527733.